Branch RA - Search Results

1

The procarcinogen hypothesis for bladder cancer: activities of individual drug metabolizing enzymes as risk factors.

Branch RA, Chern HD, Adedoyin A, Romkes-Sparks M, Lesnick TG, Persad R, Wilkinson GR, Fleming CM, Dickinson AJ, Sibley G, et al. Branch RA, et al. Pharmacogenetics. 1995;5 Spec No:S97-102. doi: 10.1097/00008571-199512001-00009. Pharmacogenetics. 1995. PMID: 7581498 Review.

2

Correlation of polymorphic expression of CYP2D6 mRNA in bladder mucosa and tumor tissue to in vivo debrisoquine hydroxylase activity.

Romkes-Sparks M, Mnuskin A, Chern HD, Persad R, Fleming C, Sibley GN, Smith P, Wilkinson GR, Branch RA. Romkes-Sparks M, et al. Among authors: branch ra. Carcinogenesis. 1994 Sep;15(9):1955-61. doi: 10.1093/carcin/15.9.1955. Carcinogenesis. 1994. PMID: 7923590

3

Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer.

Fleming CM, Persad R, Kaisary A, Smith P, Adedoyin A, Porter J, Wilkinson GR, Branch RA. Fleming CM, et al. Among authors: branch ra. Pharmacogenetics. 1994 Aug;4(4):199-207. doi: 10.1097/00008571-199408000-00004. Pharmacogenetics. 1994. PMID: 7987404

4

Association of low CYP3A activity with p53 mutation and CYP2D6 activity with Rb mutation in human bladder cancer.

Romkes M, Chern HD, Lesnick TG, Becich MJ, Persad R, Smith P, Branch RA. Romkes M, et al. Among authors: branch ra. Carcinogenesis. 1996 May;17(5):1057-62. doi: 10.1093/carcin/17.5.1057. Carcinogenesis. 1996. PMID: 8640913

5

Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6.

Adedoyin A, Arns PA, Richards WO, Wilkinson GR, Branch RA. Adedoyin A, et al. Among authors: branch ra. Clin Pharmacol Ther. 1998 Jul;64(1):8-17. doi: 10.1016/S0009-9236(98)90017-0. Clin Pharmacol Ther. 1998. PMID: 9695714 Clinical Trial.

6

The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancer.

Fleming CM, Kaisary A, Wilkinson GR, Smith P, Branch RA. Fleming CM, et al. Among authors: branch ra. Pharmacogenetics. 1992 Jun;2(3):128-34. doi: 10.1097/00008571-199206000-00004. Pharmacogenetics. 1992. PMID: 1306112

7

Frequency distribution of dapsone N-hydroxylase, a putative probe for P4503A4 activity, in a white population.

May DG, Porter J, Wilkinson GR, Branch RA. May DG, et al. Among authors: branch ra. Clin Pharmacol Ther. 1994 May;55(5):492-500. doi: 10.1038/clpt.1994.62. Clin Pharmacol Ther. 1994. PMID: 8181193 Free article.

8

Metabolic interactions of putative cytochrome P4503A substrates with alternative pathways of dapsone metabolism in human liver microsomes.

Irshaid Y, Branch RA, Adedoyin A. Irshaid Y, et al. Among authors: branch ra. Drug Metab Dispos. 1996 Feb;24(2):164-171. Drug Metab Dispos. 1996. PMID: 8742227

9

Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of P53 and retinoblastoma proteins.

Chern HD, Becich MJ, Persad RA, Romkes M, Smith P, Collins C, Li YH, Branch RA. Chern HD, et al. Among authors: branch ra. J Urol. 1996 Nov;156(5):1846-9. J Urol. 1996. PMID: 8863629

10

Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes.

Frye RF, Matzke GR, Adedoyin A, Porter JA, Branch RA. Frye RF, et al. Among authors: branch ra. Clin Pharmacol Ther. 1997 Oct;62(4):365-76. doi: 10.1016/S0009-9236(97)90114-4. Clin Pharmacol Ther. 1997. PMID: 9357387 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters